India has provided over 481 lakh doses of coronavirus vaccines to various countries, the government informed Lok Sabha on Wednesday.
In written reply to a question in Lok Sabha, Minister of State for External Affairs V Muraleedharan said external supplies are done factoring in domestic production, requirements of the national vaccination programme and requests for the Made-in-India vaccines.
The supplies will continue in the coming weeks and months in a phased manner, depending on production and needs of the national vaccination programme, he said.
India started external supplies of Made-in-India vaccines on January 20, the minister said.
Supplies are being undertaken in three ways -- grant, commercial sales by the manufacturers and through vaccine alliance GAVI's COVAX facility.
According to details given by Muraleedharan of vaccines shipped from India till March 4, out of 481.06 lakh vaccine doses sent to various countries, 73.5lakh doses have been supplied as grant assistance, 288.4 lakh on commercial basis and 119.16 lakh doses for COVAX.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)